BSPM — Biostar Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1.76 | 0.08 | 1.69 | 0.039 | 0.173 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 35.7 | 31.6 | 36.8 | 15.9 | 6.85 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 42 | 36 | 43.6 | 16.2 | 7.37 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6.98 | 7.73 | 8.48 | 6.81 | 5.87 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 70.5 | 67.6 | 81.2 | 51.4 | 42.5 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 12.7 | 4.79 | 8.91 | 7.1 | 5.62 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 12.7 | 4.79 | 8.91 | 7.1 | 5.62 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 57.8 | 62.8 | 72.3 | 44.3 | 36.9 |
Total Liabilities & Shareholders' Equity | 70.5 | 67.6 | 81.2 | 51.4 | 42.5 |
Total Common Shares Outstanding |